Helping Your Oncology Brand
Helping Your Oncology Brand Achieve Success
Mohamed "Raz" Dewji
Mohamed (“Raz”) Dewji is a clinical development and medical affairs, expert with over thirty years of experience within the global pharmaceutical industry, specifically within the oncology therapeutics arena. He has worked internationally for major global pharmaceutical companies, including BMS, Pfizer, GSK and AstraZeneca. Over the course of his career to date, Raz has held roles of increasing seniority and made significant leadership contributions to six oncology drug approvals for various cancer treatment settings: Taxol (BMS); Amifostine (US Bioscience); Sunitinib & Axitinib (Pfizer); Pazopanib (GSK); Osimertinib (AZ)
More than 30 years of international pharmaceutical industry expertise in oncology clinical development and medical affairs.
Management of global clinical trials in lung, breast, genitourinary, gastro-intestinal and other solid tumours
Highly experienced global matrix team leadership / coaching / mentoring and support to get the best from your team & brand
MRD Pharma Consultancy provides you with key services in Oncology Clinical Development and Medical Affairs. For a strategic discussion on how MRD Pharma Consultancy can support your organisation and help you deliver your goals, please contact us.
From First in Man, to late-phase clinical development and life-cycle management –including Phase III, Registration, Post-approval Evidence Generation and Real World Evidence (RWE).
Multi-channel communication platforms for virtual advisory boards and webinar presentations; Publication planning and data releases to deliver the maximum impact to your target audience; Engagement of patient advocacy groups (PAGs) and nurse forums for advisory and educational programmes.
Develop and deliver scientific symposia and congress presentations (either as a stand-alone event or part of a medical congress); Congress planning and organisation; Scientific symposia and exchange meetings.
Key Opinion Leader (KOL/KEE) development and management; Global Advisory boards and Steering Committee planning and management Live and Virtual events); Partnership with key oncology co-operative groups such as EORTC and TACT, etc.
Understanding and addressing the competitor environment to plan for optimal launch and growth.
Matrix leadership within global cross-functional oncology teams.